Clinical Trial Update: A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation [Phase 3]

View source ↗

Summary

A Phase III trial studying intensity-modulated hypofractionated radiotherapy dose escalation in prostate cancer; results status is unknown in the provided snipp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 3 | Status: UNKNOWN | Results posted: 2021-01-25